Davis Polk advised the representative of the underwriters in the offering. Gamida Cell Ltd. announced the $20 million SEC-registered follow-on offering of 12,905,000 ordinary shares. The ordinary shares...
Gamida Cell’s $20 Million Shares Offering
First Watch Restaurant’s Secondary Public Offering
Latham & Watkins represented the underwriters in the offering. First Watch Restaurant Group, Inc. (NASDAQ: FWRG), the Daytime Dining concept serving breakfast, brunch and lunch, has...
POINT Biopharma’s $125 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...
Corebridge Financial’s $1.7 Billion Initial Public Offering
Wachtell, Lipton, Rosen & Katz represented AIG in the transaction, while Cleary Gottlieb represented the underwriters. Debevoise & Plimpton advised Corebridge Financial. American International Group, Inc....
Oak Street Health’s $180.3 Million Shares Offering
Davis Polk advised the joint book-running managers in the offering. Oak Street Health, Inc. announced the $180.3 million secondary offering of 7,000,000 million shares of common stock...
Portillo’s $218.5 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Portillo’s Inc. (Nasdaq: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, closed on...
Amgen’s $3 Billion Senior Unsecured Notes Offerings
Latham & Watkins represented Amgen in the offerings, while Shearman & Sterling represented represented the underwriters. Amgen Inc. executed a senior unsecured notes offerings consisting of US$1,250,000,000 4.050%...
Evertec’s Shares Secondary Offering
Latham & Watkins represented Evertec, while Simpson Thacher represented the underwriters, led by J.P. Morgan Securities in the offering. Popular, Inc. (the “Selling Stockholder”) announced the secondary offering...
Orchestra BioMed’s Merger with Health Sciences Acquisitions Corporation 2
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...
VectivBio’s $54 Million Aggregate Financing
Homburger advised VectivBio on the deal. NKF acted as Swiss counsel to SVB Securities, Piper Sandler and LifeSci Capital in the public offering. VectivBio Holding AG (Nasdaq:...
Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants
Latham & Watkins represented the underwriters in the offering. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...
Southwest Bancshares’ $35 Million Notes Offering
Bracewell LLP represented Piper Sandler & Co. on the deal. Piper Sandler & Co. acted as the sole placement agent, in Southwest Bancshares, Inc.’s private placement of...